Showing results (2141-2150 of 3,115) with videos related to

Sort By:
Pageof 312
Lakartidningen|September 30, 2021
[Sedating antihistamines - risk of severe intoxication]Lena Thunander Sundbom, Bodil Fornstedt Wallin, Ulla Wändel Liminga, et al.
Neurology|April 14, 2022
The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect CostsBruce Bebo, Inna Cintina, Nicholas LaRocca, et al.
The American Journal of Cardiology|April 25, 2018
Relation Between Lipid Profile and New-Onset Atrial Fibrillation in Patients With Systemic Hypertension (From the Swedish Primary Care Cardiovascular Database [SPCCD])Georgios Mourtzinis, Thomas Kahan, Kristina Bengtsson Boström, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetic and metabolic studies of high-dose busulphan in adultsM Hassan, G Oberg, H Ehrsson, et al.
JMIR Research Protocols|June 25, 2025
An Intervention to Support Higher Education Teachers' Teaching Processes and Well-Being: Protocol for an Intervention StudyLiisa Postareff, Anna Parpala, Petri Nokelainen, et al.
Scientific Reports|June 25, 2025
Immunomodulation by extracorporeal ozone-based bactericide system in porcine Pseudomonas aeruginosa septic shockHenrik Rundgren, Johan Sjöholm, Sanja Juric, et al.
Archives of Neurology|February 11, 2009
Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variantsBrian S Appleby, Kristin K Appleby, Barbara J Crain, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1993
Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of ageK Blennow, A Wallin, C G Gottfries, et al.
World Journal of Surgery|June 20, 1998
Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year periodO Nilsson, J Lindeberg, J Zedenius, et al.
Arthritis Research & Therapy|April 2, 2022
Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE)Seerapani Gopaluni, Rona Smith, Donna Goymer, et al.
Pageof 312